maccura(SZ:300463)2023-04-24 16:00Research and Development - The company has increased its investment in the research and development of biochemical raw materials, aiming to reduce reliance on imports and improve the self-sufficiency rate of key raw materials[13]. - The company plans to enhance its research and development efforts to meet customer demands for cost reduction, efficiency improvement, and precise testing[46]. - The company has a strong focus on building a robust research and development system to support its positioning as a full-line supplier in the in vitro diagnostic sector[29]. - The company aims to accelerate the realization of its product development goals, focusing on systematization, serialization, automation, and independence across its product lines[46]. - The company recognizes the risk of technological innovation failure and is committed to enhancing its core technology protection mechanisms[22]. Market Position and Strategy - The company plans to enhance its competitive position by improving product quality, variety structure, research and development capabilities, and sales and service aspects[26]. - The company aims to transition from merely selling products to providing comprehensive solutions to customers, reflecting a shift in industry competition dynamics[26]. - The company is closely monitoring industry regulatory policies and is prepared to adjust its operational strategies accordingly to adapt to changes in the healthcare system[19]. - The company has reported that the domestic in vitro diagnostic industry is experiencing accelerated integration due to new procurement policies and market regulations[18]. Environmental Responsibility - During the reporting period, the company invested a total of 5.0682 million yuan in environmental governance and protection, primarily for daily maintenance and upgrades of wastewater and air pollution control facilities[56]. - The company is committed to reducing its carbon footprint as part of its sustainability initiatives, as detailed in its 2022 sustainability report[58]. - The company has implemented a comprehensive monitoring system for wastewater and air emissions, adhering to national environmental standards[52]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[83]. - The company has established temporary storage areas for hazardous waste, medical waste, and general solid waste, all compliant with environmental regulations[149]. Financial Performance and Shareholder Information - The basic earnings per share for the reporting period was RMB 1.7308, compared to RMB 1.4331 in the previous period[114]. - The net asset value per share increased from RMB 6.8150 to RMB 7.7247[114]. - The company reported a total distributable profit of RMB 707,952,208.97 for the year[183]. - The company distributed a cash dividend of RMB 3.47 per 10 shares, totaling RMB 212,526,947.73, which represents 30.02% of the distributable profit[183]. - The total share capital increased from 556,469,590 shares to 612,469,590 shares following the issuance[110]. Corporate Governance - The company has established an independent financial department with a complete financial accounting system, ensuring compliance with tax obligations and independent financial decision-making[50]. - The company has not engaged in any related party transactions during the reporting period, reflecting a focus on transparency and governance[69]. - The company’s board and supervisory board have completed their term and held elections for the new board members[105]. - The internal control system is complete, reasonable, and effective as of December 31, 2022, ensuring compliance with laws and regulations[156]. - The internal control audit report received a standard unqualified opinion, indicating no significant defects in non-financial reporting[166]. Shareholder Actions and Changes - The company’s major shareholders have pledged 80% of their shares, indicating significant leverage on their holdings[180]. - The actual controller of the company changed on March 28, 2022, with the new controllers being Tang Yong, Wang Dengming, and Liu Qilin[179]. - The company’s major shareholder Guo Lei pledged 6,200,000 shares in a repurchase transaction on October 28, 2022[173]. - The company’s major shareholder Guo Lei also released 4,020,000 shares from a previous pledge on December 12, 2022[176]. - The company has established a consistent action relationship among shareholders Tang Yong, Wang Dengming, and Liu Qilin[194].